» Articles » PMID: 11884870

Is Pharmacologic Vitreolysis Brewing?

Overview
Journal Retina
Date 2002 Mar 9
PMID 11884870
Citations 15
Authors
Affiliations
Soon will be listed here.
Citing Articles

Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications.

Liu J, Wang H, Gu W, Zhao T, Fan W, Peng S Int Ophthalmol. 2023; 43(12):4585-4593.

PMID: 37665493 PMC: 10724304. DOI: 10.1007/s10792-023-02858-0.


Hyalocytes in proliferative vitreo-retinal diseases.

Jones C, Gui W, Schumann R, Boneva S, Lange C, van Overdam K Expert Rev Ophthalmol. 2022; 17(4):263-280.

PMID: 36466118 PMC: 9718005. DOI: 10.1080/17469899.2022.2100764.


The vitreomacular interface in different types of age-related macular degeneration.

El-Hifnawy M, Ibrahim H, Gomaa A, Elmasry M Int J Ophthalmol. 2017; 10(2):246-253.

PMID: 28251084 PMC: 5313548. DOI: 10.18240/ijo.2017.02.11.


PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.

Chan C, Crosson J, Mein C, Daher N Retina. 2017; 37(10):1820-1831.

PMID: 28099316 PMC: 5642323. DOI: 10.1097/IAE.0000000000001448.


Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction.

Raczynska D, Lipowski P, Zorena K, Skorek A, Glasner P Drug Des Devel Ther. 2015; 9:6259-68.

PMID: 26664047 PMC: 4669920. DOI: 10.2147/DDDT.S88361.